Modification of the teratogenic effects of certain antineoplastic agents by combined treatment with vitamins.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001835:Body Weight; D004336:Drug Antagonism; D004357:Drug Synergism; D005260:Female; D005313:Fetal Death; D005333:Fetus / Q000187:drug effects; D008431:Maternal-Fetal Exchange; D051379:Mice; D008937:Mitomycins / Q000494:pharmacology*; D011247:Pregnancy; D012256:Riboflavin / Q000494:pharmacology; D013852:Thiotepa / Q000494:pharmacology*; D014815:Vitamins / Q000627:therapeutic use*
D008937:Mitomycins; D014815:Vitamins; D013852:Thiotepa; D012256:Riboflavin